You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite instability

Showing 1 - 25 of 1,595
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

Active, not recruiting
  • Colorectal Cancer
  • IBI310 (anti-CTLA-4 antibody)
  • Sintilimab(anti-PD-1 antibody)
  • Beijing, China
    Beijing cancer hospital
Sep 15, 2022

Colorectal Cancers With Microsatellite Instability

Active, not recruiting
  • Colorectal Cancer
  • Microsatellite Instability
    • Poitiers, Vienne, France
    • +13 more
    Aug 19, 2022

    Advanced Solid Tumors Trial (RO7589831)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Aug 16, 2023

    Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

    Not yet recruiting
    • Melanoma
    • +5 more
    • INCB 99280 with Ipilimumab
    • (no location specified)
    Jun 9, 2023

    Microsatellite Instability in Colorectal Cancers

    Completed
    • Colorectal Cancer
    • +4 more
    • Microsatellite instability analysis
    • Istanbul, Turkey
      Sultan 2. Abdulhamid Training and Research Hospital
    Dec 5, 2021

    Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial (Cadonilimab)

    Not yet recruiting
    • Colorectal Cancer Stage IV
    • +2 more
    • (no location specified)
    Jun 19, 2022

    Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)

    Recruiting
    • Gastric Cancer
    • Microsatellite Instability
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Aug 3, 2022

    Recurrent/Metastatic Gastric Cancer Trial in Seoul (Nivolumab, Paclitaxel)

    Completed
    • Recurrent/Metastatic Gastric Cancer
    • Nivolumab, Paclitaxel
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Sep 9, 2022

    Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

    Not yet recruiting
    • Adenocarcinoma - GEJ
    • Gastric Adenocarcinoma
    • (no location specified)
    Sep 26, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

    Recruiting
    • Neoadjuvant Chemoradiation Therapy
    • +3 more
    • xintilimab injection
    • Control
    • Shanghai, Shanghai, China
      Department of Colorectal Surgery in Changhai Hospital
    Aug 5, 2022

    Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Neoadjuvant therapy with PD-L1 inhibitor
    • Guangzhou, Guangdong, China
      the Third Affiliated Hospital of Sun Yat-Sen University
    May 10, 2022

    Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

    Recruiting
    • Digestive System Cancers
    • Beijing, China
      Peking University Cancer Hospital
    Oct 25, 2023

    Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

    Recruiting
    • Colorectal Neoplasms
    • Microsatellite Instability
    • temozolomide (induction),
    • pembrolizumab (treatment)
    • Milano, Italy
    • +3 more
    Sep 28, 2022

    High-Frequency Microsatellite Instability, Mismatch Repair Gene Mutation, Mutation-Negative Lynch Syndrome Trial in Houston

    Active, not recruiting
    • High-Frequency Microsatellite Instability
    • +3 more
    • Exercise Intervention
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 11, 2022

    Registry Study in MSI/dMMR Solid Tumors

    Not yet recruiting
    • DMMR Cancer
    • +2 more
      • (no location specified)
      Aug 21, 2023

      Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

      Recruiting
      • Gastric Cancer
      • +9 more
      • Tumor Infiltrating Lymphocytes (TIL)
      • Fludarabine + Cyclophosphamide combination
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 21, 2022

      POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

      Terminated
      • POLE Exonuclease Mutant Colon Cancer
      • +2 more
      • Sutton, Surrey, United Kingdom
        Royal Marsden NHS Foundation Trust
      Oct 5, 2022

      DOstarlimab in Recurrent or dMMR/MSI-H Endometrial Cancer

      Not yet recruiting
      • Endometrial Cancer
      • (no location specified)
      Feb 14, 2023

      Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

      Active, not recruiting
      • Colon Adenocarcinoma
      • +10 more
      • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 12, 2022

      Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

      Recruiting
      • Non Small Cell Lung Cancer
      • +10 more
      • Los Angeles, California
      • +4 more
      Sep 5, 2023

      Colorectal Cancer, Microsatellite Instability High Trial in Guangzhou (PD-1 inhibitor plus VEGF inhibitors)

      Recruiting
      • Colorectal Cancer
      • Microsatellite Instability High
      • PD-1 inhibitor plus VEGF inhibitors
      • Guangzhou, Guangdong, China
        651 Dongfeng Road East
      May 27, 2022